AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34587719 — intervention group
Group type: EXPERIMENTAL
Intervention: Acalabrutinib monotherapy
Number of subjects: 762
Study 35362456 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 32
Study 35362456 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 32
Study 33415555 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized isotonic magnesium (1024 mg/h)
Number of subjects: 28
Study 33415555 — intervention group
Group type: COMPARATOR
Intervention: Intravenous magnesium (200 mg/kg over 30 min, followed by 50 mg/kg/h)
Number of subjects: 28
Study 35290431 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconference training
Number of subjects: 41
Study 35290431 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face training
Number of subjects: 41
Study 33410261 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic immune-inflammation index (SII)
Number of subjects: 852
Study 33410261 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy
Number of subjects: 852
Study 33410261 — intervention group
Group type: EXPERIMENTAL
Intervention: pTNM stage
Number of subjects: 852
Study 33410261 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet–lymphocyte ratio (PLR)
Number of subjects: 852
Study 33410261 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting 5-year prognosis
Number of subjects: 852
Study 32320171 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate nostril breathing (ANB) exercise for 10 min/day over 4 weeks
Number of subjects: 100
Study 32320171 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 34530112 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g/d of 85% cocoa chocolate (DC85)
Number of subjects: 48
Study 34530112 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% cocoa chocolate (DC70)
Number of subjects: 48
Study 34530112 — intervention group
Group type: COMPARATOR
Intervention: No chocolate (control group, CON)
Number of subjects: 48
Study 34635353 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme alginogel
Number of subjects: 0
Study 34635353 — intervention group
Group type: COMPARATOR
Intervention: Copper and zinc chelate gel (coppergel)
Number of subjects: 0
Study 36114615 — intervention group
Group type: COMPARATOR
Intervention: DASH diet
Number of subjects: 35
Study 36114615 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet plus physical activity (DASHPED)
Number of subjects: 35
Study 33428746 — intervention group
Group type: EXPERIMENTAL
Intervention: Centers for Disease Control (CDC) video educational materials (Vi)
Number of subjects: 118
Study 33428746 — intervention group
Group type: EXPERIMENTAL
Intervention: CDC written educational materials (Wr)
Number of subjects: 118
Study 32879890 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic Musculoskeletal Questionnaire (NMQ‐E)
Number of subjects: 207
Study 32879890 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutch Musculoskeletal Questionnaire (DMQ)
Number of subjects: 207
Study 34091935 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-level intervention (counseling)
Number of subjects: 331
Study 34091935 — intervention group
Group type: COMPARATOR
Intervention: Building-level intervention
Number of subjects: 331
Study 34091935 — intervention group
Group type: EXPERIMENTAL
Intervention: Building-level intervention followed by individual intervention
Number of subjects: 331
Study 34091935 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-level intervention followed by building intervention
Number of subjects: 331
Study 34091935 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 331
Study 34091935 — intervention group
Group type: COMPARATOR
Intervention: Building-level intervention after individual intervention
Number of subjects: 331
Study 33840773 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (up to 2 mg daily)
Number of subjects: 156
Study 33840773 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 33955479 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal wear of dentures
Number of subjects: 77
Study 33955479 — intervention group
Group type: COMPARATOR
Intervention: Nocturnal nonwear of dentures
Number of subjects: 77
Study 32653571 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain MRI/S after 24 vs. 72 hours of hypothermia
Number of subjects: 23
Study 32653571 — intervention group
Group type: EXPERIMENTAL
Intervention: T2 brain lesions in the lentiform nuclei
Number of subjects: 23
Study 32653571 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate and NAA concentrations
Number of subjects: 23
Study 32653571 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI/S biomarkers
Number of subjects: 23
Study 33999270 — intervention group
Group type: EXPERIMENTAL
Intervention: Dignity therapy (N = 32)
Number of subjects: 66
Study 33999270 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 34)
Number of subjects: 66
Study 35366050 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk best practice communication strategy
Number of subjects: 1017
Study 35366050 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional support communication strategy
Number of subjects: 1017
Study 35366050 — intervention group
Group type: EXPERIMENTAL
Intervention: Teach-back communication strategy
Number of subjects: 1017
Study 35366050 — intervention group
Group type: COMPARATOR
Intervention: Basic condition (control)
Number of subjects: 1017
Study 33581727 — intervention group
Group type: EXPERIMENTAL
Intervention: Penehyclidine
Number of subjects: 218
Study 33581727 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline
Number of subjects: 218
Study 36327627 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal exercise program (aerobic exercise, resistance exercise, and pelvic floor muscle training)
Number of subjects: 33
Study 36327627 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor muscle training (PFMT) only
Number of subjects: 33
Study 34717765 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE®
Number of subjects: 57
Study 34717765 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 57
Study 32112496 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group therapy (CBT) for 14 weeks
Number of subjects: 75
Study 32112496 — intervention group
Group type: COMPARATOR
Intervention: Unstructured group meetings
Number of subjects: 75
Study 616625620 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginseng extract (300 mg)
Number of subjects: 48
Study 616625620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 36085339 — intervention group
Group type: EXPERIMENTAL
Intervention: Levoketoconazole
Number of subjects: 79
Study 36085339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 33001324 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical tibial nerve stimulation (TTNS)
Number of subjects: 340
Study 33001324 — intervention group
Group type: COMPARATOR
Intervention: Sham electrical stimulation
Number of subjects: 340
Study 35024710 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole chickpeas
Number of subjects: 13
Study 35024710 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickpea puree
Number of subjects: 13
Study 35024710 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickpea pasta
Number of subjects: 13
Study 35024710 — intervention group
Group type: COMPARATOR
Intervention: Mashed potato (control)
Number of subjects: 13
Study 33230640 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-kindness to the mind condition
Number of subjects: 90
Study 33230640 — intervention group
Group type: COMPARATOR
Intervention: Self-kindness to the mind and body condition
Number of subjects: 90
Study 32438024 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial participants with structured diabetes-specific education; specific intervention details not provided.
Number of subjects: 0
Study 32438024 — intervention group
Group type: COMPARATOR
Intervention: Original RCT findings; specific intervention details not provided.
Number of subjects: 0
Study 34412166 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg pure CBD
Number of subjects: 17
Study 34412166 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg pure CBD
Number of subjects: 17
Study 34412166 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg pure CBD
Number of subjects: 17
Study 34412166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 33745898 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive medical therapy (IMT) including high-intensity statins and ACE-I or ARB
Number of subjects: 4422
Study 33745898 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 4422
Study 33745898 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive medical therapy (IMT)
Number of subjects: 4422
Study 34599507 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based demonstration
Number of subjects: 46
Study 34599507 — intervention group
Group type: COMPARATOR
Intervention: Slide-based demonstration
Number of subjects: 46
Study 34323929 — intervention group
Group type: EXPERIMENTAL
Intervention: Web app‐based music listening intervention delivered via headphones
Number of subjects: 311
Study 34323929 — intervention group
Group type: COMPARATOR
Intervention: Noise‐canceling headphones without music (Control)
Number of subjects: 311
Study 35150246 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 575
Study 35150246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 575
Study 33601731 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Interpretation Bias Training (IBT)
Number of subjects: 50
Study 33601731 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline learning rate
Number of subjects: 50
Study 32602261 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound-guided cyanoacrylate obturation (EUS-CYA)
Number of subjects: 30
Study 32602261 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (EGD-CYA)
Number of subjects: 30
Study 34922314 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-sedation
Number of subjects: 700
Study 34922314 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-sedation failure
Number of subjects: 700
Study 34922314 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-sedation success
Number of subjects: 700
Study 34922314 — intervention group
Group type: COMPARATOR
Intervention: Light sedation
Number of subjects: 700
Study 33811557 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 42
Study 33811557 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 42
Study 35732378 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced training for cognitive behavioural therapists
Number of subjects: 600
Study 35732378 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment by IAPT therapists
Number of subjects: 600
Study 32000046 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Scapular Assistance Test (n = 25)
Number of subjects: 50
Study 32000046 — intervention group
Group type: COMPARATOR
Intervention: Negative Scapular Assistance Test (n = 25)
Number of subjects: 50
Study 35395801 — intervention group
Group type: EXPERIMENTAL
Intervention: RPE
Number of subjects: 40
Study 35395801 — intervention group
Group type: EXPERIMENTAL
Intervention: MARPE
Number of subjects: 40
Study 33617061 — intervention group
Group type: EXPERIMENTAL
Intervention: FLY
Number of subjects: 27
Study 33617061 — intervention group
Group type: EXPERIMENTAL
Intervention: NHE
Number of subjects: 27
Study 33150715 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine–isosorbide dinitrate (H-ISDN)
Number of subjects: 44
Study 33150715 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 44
Study 34838156 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabrafenib 150 mg twice daily plus trametinib 2 mg once daily orally
Number of subjects: 58
Study 33441702 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 80
Study 33441702 — intervention group
Group type: COMPARATOR
Intervention: Control (no probiotics)
Number of subjects: 80
Study 35808375 — intervention group
Group type: EXPERIMENTAL
Intervention: WAT-based exercise training (ET) program, 1 year, three times per week
Number of subjects: 42
Study 32350790 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation Schedule for Children with Autism-Anxiety, Behaviour and Parenting (OSCA-ABP)
Number of subjects: 83
Study 33031860 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard SMR training session with positive expectancy (placebo condition)
Number of subjects: 30
Study 33031860 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard SMR training session with negative expectancy (nocebo condition)
Number of subjects: 30
Study 33031860 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard SMR training session with no expectancy (no-expectancy condition)
Number of subjects: 30
Study 33031860 — intervention group
Group type: COMPARATOR
Intervention: Standard SMR training session
Number of subjects: 30
Study 32654804 — intervention group
Group type: COMPARATOR
Intervention: Standard digital mammography
Number of subjects: 0
Study 32654804 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomosynthesis mammography
Number of subjects: 0
Study 34289443 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure using vaccaria seeds
Number of subjects: 54
Study 34289443 — intervention group
Group type: COMPARATOR
Intervention: Placebo auricular acupressure using vaccaria seeds
Number of subjects: 54
Study 32085669 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab-based neoadjuvant therapy
Number of subjects: 52
Study 32085669 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab-based neoadjuvant therapy with ct-miR-148a and ct-miR-140-5p
Number of subjects: 52
Study 36064284 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) treatment
Number of subjects: 90
Study 33135865 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin/metformin FDC tablet (2.5/500 mg or 7.5/850 mg)
Number of subjects: 32
Study 33135865 — intervention group
Group type: COMPARATOR
Intervention: Canadian-sourced metformin coadministered with ertugliflozin
Number of subjects: 32
Study 33372542 — intervention group
Group type: EXPERIMENTAL
Intervention: 30SMA-P (using social networks on a smartphone prior to exercise)
Number of subjects: 12
Study 33372542 — intervention group
Group type: EXPERIMENTAL
Intervention: SMA-INT (using social networks on a smartphone intra-session)
Number of subjects: 12
Study 33372542 — intervention group
Group type: COMPARATOR
Intervention: CON (watching TV before exercise)
Number of subjects: 12
Study 32893063 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 0
Study 32893063 — intervention group
Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 0
Study 36333268 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib (80 mg once daily)
Number of subjects: 44
Study 36333268 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib (80 mg once daily) and Savolitinib (300 mg twice daily)
Number of subjects: 44
Study 33428358 — intervention group
Group type: EXPERIMENTAL
Intervention: CBRNe PPE
Number of subjects: 36
Study 33428358 — intervention group
Group type: COMPARATOR
Intervention: No PPE
Number of subjects: 36
Study 32521448 — intervention group
Group type: EXPERIMENTAL
Intervention: Website designs with risk indicators
Number of subjects: 1441
Study 32521448 — intervention group
Group type: EXPERIMENTAL
Intervention: Website designs grouping chemicals with harms
Number of subjects: 1441
Study 36120338 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxing Ganshi Decoction (MGD)
Number of subjects: 71
Study 36120338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 33399541 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity Tracker (AT) with text message feedback from an accredited exercise physiologist (AEP)
Number of subjects: 117
Study 33399541 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone Counseling (TC) with phone calls from an AEP
Number of subjects: 117
Study 33399541 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 117
Study 33399541 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity Tracker (AT)
Number of subjects: 117
Study 33399541 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone Counseling (TC)
Number of subjects: 117
Study 35392336 — intervention group
Group type: EXPERIMENTAL
Intervention: Education based on Kolb's learning style (four 45 minutes sessions, two sessions per week)
Number of subjects: 62
Study 35392336 — intervention group
Group type: COMPARATOR
Intervention: Control group received the same educational content presented with a lecture and a booklet
Number of subjects: 62
Study 33382752 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 impact assessment
Number of subjects: 52
Study 34767869 — intervention group
Group type: EXPERIMENTAL
Intervention: Deucravacitinib (selective TYK2 inhibitor)
Number of subjects: 0
Study 34767869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33974621 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-led HIV self-testing (HIVST)
Number of subjects: 7920
Study 34620570 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-based endovascular renal denervation (RDN)
Number of subjects: 324
Study 34620570 — intervention group
Group type: EXPERIMENTAL
Intervention: CTA or MRA imaging
Number of subjects: 324
Study 33887241 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (25 μg)
Number of subjects: 1674
Study 33887241 — intervention group
Group type: COMPARATOR
Intervention: Slow-release dinoprostone pessary (10 μg)
Number of subjects: 1674
Study 32901242 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy with lavender fragrance during IANB
Number of subjects: 46
Study 32901242 — intervention group
Group type: COMPARATOR
Intervention: IANB without fragrance
Number of subjects: 46
Study 35952956 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Pneumatic Compression Device (NPCD)
Number of subjects: 50
Study 35952956 — intervention group
Group type: COMPARATOR
Intervention: Active Pneumatic Compression Device (APCD)
Number of subjects: 50
Study 33476803 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (10 mg/kg, intravenous, every 2 weeks for ≤12 months)
Number of subjects: 713
Study 33476803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 713
Study 32851060 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Rhythmic Gymnastics (ARG) program, 16 weeks, 3 sessions per week, 50 minutes each session
Number of subjects: 22
Study 32851060 — intervention group
Group type: COMPARATOR
Intervention: Traditional control group
Number of subjects: 22
Study 35776879 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walking Test (ISWT)
Number of subjects: 26
Study 32731478 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple beverage (234 mg flavanols)
Number of subjects: 32
Study 32731478 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee berry beverage (440 mg chlorogenic acid)
Number of subjects: 32
Study 32731478 — intervention group
Group type: EXPERIMENTAL
Intervention: Blueberry beverage (300 mg anthocyanins)
Number of subjects: 32
Study 34050269 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (HT) at 33.5°C for 1-25 hours (n=6)
Number of subjects: 12
Study 34050269 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (NT) (n=6)
Number of subjects: 12
Study 34050269 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (HT)
Number of subjects: 12
Study 33573926 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg methylprednisolone
Number of subjects: 40
Study 33573926 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress-dose corticosteroid (SDC) regimen
Number of subjects: 40
Study 33573926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35692065 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone acetate group (n=28)
Number of subjects: 81
Study 35692065 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined with local injection Triamcinolone acetonide group (n=30)
Number of subjects: 81
Study 35692065 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=23)
Number of subjects: 81
Study 34182552 — intervention group
Group type: EXPERIMENTAL
Intervention: ICBT
Number of subjects: 170
Study 34182552 — intervention group
Group type: EXPERIMENTAL
Intervention: IIPT
Number of subjects: 170
Study 34182552 — intervention group
Group type: COMPARATOR
Intervention: Wait-list
Number of subjects: 170
Study 36065092 — intervention group
Group type: EXPERIMENTAL
Intervention: ZYIL1 (oral NLRP3 inflammasome inhibitor)
Number of subjects: 48
Study 35010722 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (conditioning activity)
Number of subjects: 11
Study 35010722 — intervention group
Group type: COMPARATOR
Intervention: Control group (no conditioning activity)
Number of subjects: 11
Study 32706442 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric hamstring training at long-muscle length
Number of subjects: 40
Study 34013673 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 88
Study 34013673 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy (control)
Number of subjects: 88
Study 33764850 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0
Study 33764850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36135055 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncokompas (eHealth application)
Number of subjects: 138
Study 36135055 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (waiting-list control group)
Number of subjects: 138
Study 33831250 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin–tazobactam
Number of subjects: 0
Study 33831250 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 0
Study 32735426 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute rest interval (RI-3)
Number of subjects: 21